Diabetes, nitric oxide, and heat shock proteins [3]

Diabetes Care

Volumn 26, Issue 3, 2003, Pages 951-952

  Hooper, Philip L ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b Box 245 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEAT SHOCK PROTEIN 70; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

CELL PROTECTION; DIABETES MELLITUS; DIABETOGENESIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN EXPRESSION;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HEAT-SHOCK PROTEINS; HUMANS; NITRIC OXIDE;

EID: 0042532281     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.3.951     Document Type: Letter

References (14)

1. Benjamin IJ, McMillan DR: Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ Res 83:117-132, 1998
2. Kurucz I, Morva A, Vaag A, Eriksson KF, Huang X, Groop L, Koranyi L: Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes 51:1102-1109, 2002
3. , Patti ME, Butte A, Cusi K, Kohane I, Landaker EJ, Defronzo R, Mandarino LJ, Kahn CR: Analysis of differential gene expression in skeletal muscle from subjects with insulin resistance and type 2 diabetes (Abstract). Diabetes 50 (Suppl. 2):A247, 2001
4. Strokov IA, Manukhina EB, Bakhtina LY, Malyshev IY, Zoloev GK, Kazikhanova SI, Ametov AS: The function of endogenous protective systems in patients with insulin-dependent diabetes mellitus and polyneuropathy: effect of antioxidant therapy. Bull Exp Biol Med 130:986-990, 2000
5. Malyshev IY, Manukhina EB, Mikoyan VD, Kubrina LN, Vanin AF: Nitric oxide is involved in heat-induced HSP70 accumulation. FEBS Lett 370:159-62, 1995
6. Suematsu Y, Ohtsuka T, Horimoto H, Maeda K, Nakai Y, Mieno S, Takamoto S: Long-term treatment with nipradilol, a nitric oxide-releasing beta-adrenergic blocker, enhances postischemic recovery and limits infarct size. Ann Thorac Surg 73:173-179, 2002
7. Hattori Y, Nakanishi N, Kasai K: Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells. Cardiovasc Res 54:649-658, 2002
8. Angiotensin-converting: enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism. Circulation 105:2785-2790, 2002
9. Fujishima S, Ohya Y, Nakamura Y, Onaka U, Abe I, Fujishima M: Troglitazone, an insulin sensitizer, increases forearm blood flow in humans. Am J Hypertens 11:1134-1137, 1998
10. Roberts CK, Barnard RJ, Jasman A, Balon TW: Acute exercise increases nitric oxide synthase activity in skeletal muscle. Am J Physiol 277 (2 Pt 1):E390-E394, 1999
11. Walsh RC, Koukoulas I, Gamham A, Moseley PL, Hargreaves M, Febbraio MA: Exercise increases serum Hsp72 in humans. Cell Stress Chaperones 6:386-393, 2001
12. Vigh L, Literati PN, Horvath I, Torok Z, Balogh G, Glatz A, Kovacs E, Boros I, Ferdinandy P, Farkas B, Jaszlits L, Jednakovits A, Koranyi L, Maresca B: Bimoclomol: a nontoxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects. Nat Med 3:1150-1154, 1997
13. Kurthy M, Mogyorosi T, Nagy K, Kukorelli T, Jednakovits A, Talosi L, Biro K: Effect of BRX-220 against peripheral neuropathy and insulin resistance in diabetic rat models. Ann N Y Acad Sci 967:482-489, 2002
14. Hooper PL: Hot-tub therapy for type 2 diabetes mellitus. N Engl J Med 341:924-925, 1999